GlassScriptPhysician profile
Erin Pennison
NPI 1023078953
$403.93
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $45.72 · 2021: $11.20 · 2022: $102 · 2023: $59.68 · 2024: $72.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $132.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $60.52 | 2019-2022 | |
| Hologic Sales and Service, LLC | $53.98 | 2019-2024 | Myosure Tissue Removal Device, Fluent Fluid Management System |
| Pfizer INC. | $47.51 | 2019-2022 | |
| Novo Nordisk INC | $35.00 | 2023-2024 | Wegovy, Saxenda |
| Astellas Pharma US INC | $33.43 | 2023-2024 | Veozah |
| Lupin INC. | $29.52 | 2019 | |
| Boston Scientific Corporation | $27.09 | 2020-2021 | |
| Becton, Dickinson and Company | $24.48 | 2022 | |
| Asensus Surgical, INC. | $24.20 | 2023 | Senhance |
| Therapeuticsmd, INC. | $22.65 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $16.78 | 2020 | |
| Organon LLC | $15.72 | 2022 | |
| Millicent US INC | $13.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Pennison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.